You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Toll-Like Receptor 7 (TLR-7)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear

Not yet recruiting
  • COVID-19 Respiratory Infection
  • blood sample
  • (no location specified)
Oct 21, 2021

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)

Withdrawn
  • Itch
  • Zyclara 3.75 % Topical Cream
  • +5 more
  • Aalborg, Nordjylland, Denmark
    Aalborg University
Jan 13, 2021

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)

Completed
Has Results
  • Cancer
  • Neoplasms
  • Berlin, Germany
    GSK Investigational Site
Nov 13, 2020

Genetic Predisposition Trial in Tübingen (Multi-OMICS)

Recruiting
  • Genetic Predisposition
  • Multi-OMICS
  • Tübingen, Germany
    University Hospital Tübingen
May 17, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Minneapolis (852A)

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Aug 21, 2019

HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

Recruiting
  • HIV-1-infection
  • Umlazi, South Africa
    FRESH Clinical Research Site: Females Rising through Education,
Jan 4, 2023

HIV/AIDS Trial in Spain (ChAdOx1.HTI, MVA.HTI, GS-9620)

Active, not recruiting
  • HIV/AIDS
  • ChAdOx1.HTI
  • +4 more
  • Badalona, Barcelona, Spain
  • +8 more
Jul 30, 2021

Rheumatoid Arthritis Trial (Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg)

Not yet recruiting
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • (no location specified)
Jul 27, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Bipolar Depression, MDD Trial in Chi?inau (Palmitoylethanolamide)

Recruiting
  • Bipolar Depression
  • Major Depressive Disorder
  • Chișinău, Moldova, Republic of
    State University of Medicine and Pharmacy " Nicolae Testemitsanu
Sep 26, 2023

ASO and Beta-hemolytic Group A Streptococcus Infections in

Unknown status
  • Attention Deficit-Hyperactivity Disorder
  • Antistreptolysin O Test
  • +3 more
  • Orbassano, Torino, Italy
    AOU San Luigi Gonzaga di Orbassano
Mar 23, 2020

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus
  • (no location specified)
Dec 12, 2022

Cervix Dysplasia, HPV Infection Trial in Herne (DEFLAGYN vaginal gel)

Not yet recruiting
  • Cervix Dysplasia
  • HPV Infection
  • DEFLAGYN vaginal gel
  • Herne, North Rhine-Westphalia, Germany
    Marien Hospital Herne
Aug 19, 2022

Periodontal Inflammation Trial in Ajman (saliva analysis for Toll like receptor activity)

Completed
  • Periodontal Inflammation
  • saliva analysis for Toll like receptor activity
  • Ajman, Dubai, United Arab Emirates
    Ajman University
Dec 16, 2019

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023